New Key Statistics Module, Z-Score and F-Score
SHSE:688513 Key Ratios
Market Cap ¥ M | 6,793.49 |
Enterprise Value ¥ M | 5,509.51 |
P/E(ttm) | 28.14 |
PE Ratio without NRI | 29.17 |
Forward PE Ratio | -- |
Price/Book | 2.59 |
Price/Sales | 5.87 |
Price/Free Cash Flow | 44.23 |
Price/Owner Earnings | 155.41 |
Payout Ratio % | 0.29 |
Revenue (TTM) ¥ M | 1,154.00 |
EPS (TTM) ¥ | 2.01 |
Beneish M-Score | -2.42 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 9.80 |
y-y EBITDA Growth Rate % | -6.60 |
EV-to-EBIT | 21.42 |
EV-to-EBITDA | 21.42 |
PEG | 2.98 |
Shares Outstanding M | 120.09 |
Net Margin (%) | 20.84 |
Operating Margin % | 19.45 |
Pre-tax Margin (%) | 21.96 |
Quick Ratio | 2.59 |
Current Ratio | 2.86 |
ROA % (ttm) | 7.46 |
ROE % (ttm) | 9.39 |
ROIC % (ttm) | 13.31 |
Dividend Yield % | 0.99 |
Altman Z-Score | 6.92 |
SHSE:688513 Number of Guru Trades
SHSE:688513 Volume of Guru Trades
Gurus Latest Trades with SHSE:688513
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:688513 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Chengdu Easton Biopharmaceuticals Co Ltd Insider Transactions
No Available Data